Canada markets closed

Barinthus Biotherapeutics plc (2AB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.9200-0.0300 (-1.54%)
At close: 08:06AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
802
802
44,703
268
4,821
Operating Expenses
Research Development
41,413
41,413
41,110
16,370
11,108
Selling General and Administrative
39,842
39,842
6,394
25,118
10,480
Total Operating Expenses
81,255
81,255
47,504
41,488
21,588
Operating Income or Loss
-80,453
-80,453
-2,801
-41,220
-16,767
Interest Expense
28
28
19
2,668
3,600
Total Other Income/Expenses Net
1,082
1,082
567
-7,254
2,529
Income Before Tax
-76,522
-76,522
850
-51,140
-17,838
Income Tax Expense
-3,075
-3,075
-4,471
-28
95
Income from Continuing Operations
-73,447
-73,447
5,321
-51,112
-17,933
Net Income
-73,347
-73,347
5,342
-50,865
-17,706
Net Income available to common shareholders
-73,347
-73,347
5,342
-50,865
-17,706
Basic EPS
-2.03
-1.91
0.14
-1.96
-371.62
Diluted EPS
-2.03
-1.91
0.14
-1.96
-371.62
Basic Average Shares
38,078
38,386
37,248
25,894
47.646
Diluted Average Shares
38,240
38,386
38,169
25,894
47.646